Pharmacogenomics Hub in a strengthened IMGGE

Informazioni relative al progetto

PharmGenHUB

ID dell’accordo di sovvenzione: 101059870

DOI

10.3030/101059870

Progetto chiuso

Data della firma CE 6 Aprile 2022

Data di avvio 1 Luglio 2022

Data di completamento 30 Giugno 2025

Finanziato da

• Widening participation and spreading excellence

Costo totale

€ 1 339 250,00

Contributo UE

€ 1 339 250,00

Coordinato da

INSTITUT ZA MOLEKULARNU GENETIKU I GENETICKO INZENJERSTVO
Serbia

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

Documents, reports (8)

First report on the bioinformatics trainings at UPAT
Strengthened transferable and soft skills of the IMGGE staff
Setting up a RMU at IMGGE

RMU will be set up at the kickoff meeting M1 by appointing staff from IMGGE

First report on the human iPSC-based model system trainings at UNITS

First report on the human iPSCbased model system trainings at UNITS

Plan for dissemination, exploitation and communication (kick-off meeting)

Initial plan for dissemination exploitation and communication

Kick-off meeting report and naming the Project Management Board and Advisory Board

Kickoff meeting report and naming the Project Management Board and Advisory Board

First report on the advanced statistics trainings at UL
Data management plan (Kick-off meeting)

Data management plan initial following Kickoff meeting

Websites, patent fillings, videos etc. (2)

Interactive web site

Interactive web site will be created where information regarding the aims of the Project progress in achieving goals and relevant supporting will be available at all times and updated monthly from month 6 The web site will be also accessible through IMGGE web site wwwimggebgacrs and will be bilingual Serbian and English languages

Leaflets containing information on significance and clinical use of pharmacogenomics markers.

Leaflets containing information on significance and clinical use of pharmacogenomics markers Three leaflets are planned

Pubblicazioni

Peer reviewed articles (3)

Comprehensive pharmacogenomics profiling of the Serbian population

Autori: Marina Jelovac, Djordje Pavlovic, Biljana Stankovic, Nikola Kotur, Bojan Ristivojevic, Sonja Pavlovic, Branka Zukic
Pubblicato in: Frontiers in Pharmacology, Numero 16, 2025, ISSN 1663-9812
Editore: Frontiers Media SA
DOI: 10.3389/FPHAR.2025.1553536

The long non-coding RNA GAS5 contributes to the suppression of inflammatory responses by inhibiting NF-κB activity

Autori: Debora Curci, Biljana Stankovic, Nikola Kotur, Letizia Pugnetti, Vladimir Gasic, Maurizio Romano, Branka Zukic, Giuliana Decorti, Gabriele Stocco, Marianna Lucafò, Sonja Pavlovic
Pubblicato in: Frontiers in Pharmacology, Numero 15, 2024, ISSN 1663-9812
Editore: Frontiers Media SA
DOI: 10.3389/FPHAR.2024.1448136

The Sixth European Society of Pharmacogenomics and Personalised Therapy Congress

Autori: van Schaik RH, Manolopoulos VG, Daly AK, Niemi M, Zukic B, Patrinos GP, Primorac D, Swen JJ, Ingelman-Sundberg M, Morris T, Molden E, Müller D, Pavlovic S, Russmann S, Ansari M, Henricks LM, den Broek WV, Florindi F, Bozina N, Akin D, Christrup L, Llerena
Pubblicato in: Pharmacogenomics, Numero 24(5), 2023, ISSN 1462-2416
Editore: Ashley Publications Ltd.
DOI: 10.2217/PGS-2023-0013